Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

257

HTML

2156

Figures (1-3)

176

Tables (1-1)

152

Sum=2741

Mar 28, 2005 (publication date) through Aug 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Mar 28, 2005; 11(12): 1769-1774
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1769

Full Size Figure Download Figure

Figure 2 Cases of clinically relevant scores for depression according to HADS (stratified for therapy subgroups).

Citation: Kraus MR, Schäfer A, Csef H, Scheurlen M. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1769-1774
URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1769.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1769